News & Trends - Pharmaceuticals

Sanofi reports positive pre-clinical results for COVID-19 vaccine candidate

Health Industry Hub | October 16, 2020 |
[Total: 1    Average: 5/5]

Pharma News: Sanofi and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, announced the preclinical results for MRT5500, a mRNA-based vaccine candidate against SARS-CoV-2, the virus that causes COVID-19 disease.

Sanofi is already conducting phase I/II clinical trials with its GlaxoSmithKline-partnered vaccine. This particular vaccine candidate uses the same recombinant protein-based technology as one of Sanofi’s seasonal influenza vaccines with GSK’s established pandemic adjuvant technology.

Preclinical evaluation of Sanofi and Translate Bio’s vaccine candidate MRT5500 demonstrated a favourable immune response profile against SARS-CoV-2. A Phase 1/2 clinical trial is anticipated to begin in the fourth quarter of 2020.

“To tackle this global pandemic, we must look to both the strong knowledge we have from years of infectious disease expertise and the promise of new, innovative technologies,” said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur. “Today’s presentation of these positive results is another development milestone for providing a safe and effective potential vaccine against SARS-CoV2 and shows how promising this technology is. We are looking forward to working on next steps with our partner Translate Bio to bring this technology to people worldwide.”

“The rapid development of effective vaccines to address the COVID-19 pandemic continues to be an urgent global public health need and I am encouraged by the progress we’ve made to date with our partner Sanofi Pasteur toward the development of a promising mRNA vaccine candidate,” said Ronald Renaud, Chief Executive Officer at Translate Bio. “The preclinical results we report in this paper demonstrate the ability of MRT5500 to elicit a favourable immune response in both mice and non-human primates. Importantly, these results provide additional support for using our mRNA platform to potentially expedite the development of alternative approaches to traditional vaccines.”


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Medtronic recognised in the 2020 AFR BOSS most innovative health companies list

Medtronic recognised in the 2020 AFR BOSS most innovative health companies list

Health Industry Hub | October 23, 2020 |

MedTech News: Medtronic Australasia was proud to be recognised as one of Australia and New Zealand’s most innovative companies –ranking […]

More


News & Trends - Biotechnology

Biotech News - Ground-breaking COVID-19 test to not only identify virus but whether patient is infectious

Ground-breaking COVID-19 test to not only identify virus but whether patient is infectious

Health Industry Hub | October 23, 2020 |

Please log in to Health Industry Hub to view this content.
More


News & Trends - Pharmaceuticals

Pharma News - GSK confirms manufacturing site closure at end of 2022

GSK confirms manufacturing site closure at end of 2022

Health Industry Hub | October 22, 2020 |

Pharma News: In July 2020, GSK Australia announced to employees and stakeholders that the Boronia site in VIC would exit […]

More


Leadership & Management

Leadership Management Qualities - Creating the ‘light bulb moment’ on unconscious bias

Creating the ‘light bulb moment’ on unconscious bias

Health Industry Hub | October 21, 2020 |

Please log in to Health Industry Hub to view this content.
More